Stanford, California 94305

  • Lung Cancer

Purpose:

The purpose of the study is to identify a surrogate serum marker for tumor hypoxia in patients with lung cancers.


Criteria:

Inclusion Criteria:- Newly diagnosed patients with lung cancer who are undergoing surgical resection of their tumors Exclusion Criteria:- Patients without non-small cell lung cancer


NCT ID:

NCT00185913


Primary Contact:

Principal Investigator
Quynh-Thu Le
Stanford University


Backup Contact:

N/A


Location Contact:

Stanford, California 94305
United States



There is no listed contact information for this specific location.

Site Status: N/A


Data Source: ClinicalTrials.gov

Date Processed: March 30, 2020

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.


Click to view Full Listing

This study is not currently recruiting Study Participants on ClinicalConnection.com. The form below is not enabled.